Exagen Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:XGN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -10.67 M-2.88 M2.94 M-3.01 M-10.42 M3.99 M -6.5 M Cash from investing activities -107 K-209 K-275 K-35 K-228 K-543 K -1.08 M Cash from financing activities -64 K21.93 M2.95 M-384 K-62 K-370 K 2.13 M Free cash flow -10.67 M-2.88 M2.67 M-3.06 M-10.64 M3.44 M -7.59 M

News

Exagen Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-08-05

Exagen: The Path To Profitability Just Became More Credible (NASDAQ:XGN)

Exagen Inc. (XGN) Q2 2026 Earnings Call Transcript

Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates

Exagen: A Small Diagnostics Company Approaching An Inflection Point (NASDAQ:XGN)

How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%

Exagen Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:XGN) 2026-05-12

Exagen Inc. (XGN) Q1 2026 Earnings Call Transcript

Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates

AtriCure (ATRC) Reports Break-Even Earnings for Q1

Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates

KeyBanc cuts Exagen stock price target on pricing headwinds